TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
1.180
+0.060 (5.36%)
Dec 31, 2025, 4:00 PM EST - Market closed
TELA Bio Market Cap
TELA Bio has a market cap or net worth of $52.55 million as of December 31, 2025. Its market cap has decreased by -51.84% in one year.
Market Cap
52.55M
Enterprise Value
66.41M
1-Year Change
-51.84%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since November 8, 2019, TELA Bio's market cap has decreased from $146.94M to $52.55M, a decrease of -64.24%. That is a compound annual growth rate of -15.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 52.55M | -55.83% |
| Dec 31, 2024 | 118.95M | -26.62% |
| Dec 29, 2023 | 162.12M | -26.42% |
| Dec 30, 2022 | 220.33M | 18.68% |
| Dec 31, 2021 | 185.65M | -14.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.87B |
| Johnson & Johnson | 500.07B |
| AbbVie | 407.98B |
| UnitedHealth Group | 297.97B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 264.63B |
| Novo Nordisk | 229.27B |